Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Type 2 diabetes for at least 6 months~* Insulin naive. Short term insulin treatment (7 days or less within the last 6 months) is allowed~* Previous treatment with oral antidiabetic drugs for at least 4 months~* Judged by the investigator to be eligible for an insulin analogue plus oral antidiabetic drug treatment regimen~* BMI below 40 kg/m2~* HbA1c between 7-12%~* Able and willing to perform self-plasma glucose monitoring~Exclusion Criteria:~* The receipt of any other investigational drug within 4 weeks before screening~* A history of drug or alcohol abuse within the last 12 months~* Severe, uncontrolled hypertension~* Known or suspected allergy to trial products or related products

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).